Vi has launched a new suite of AI agents specifically designed for the healthcare, life sciences, and wellness industries. These agents act as an AI execution layer integrated across Vi's existing applications—Activate, Engage, and Operate—aiming to optimize decisions for patients, care teams, and operational workflows.
With one of the largest datasets of clinical, behavioral, and operational signals globally, Vi's agents enable real-time decision-making. Their applications include enhancing patient navigation, improving physician recommendations, accelerating clinical trials, and optimizing drug commercialization. So far, Vi has successfully supported the market introduction of over 50 drugs and generated more than $2 billion in measurable value for its partners, impacting the care of over 190 million lives.
The company’s ambitious vision is to achieve health abundance, ensuring that every individual has access to affordable and effective healthcare, regardless of their financial situation or geographic location. This commitment to improving healthcare is underscored by a significant financial milestone: Vi completed a $145 million funding transaction, raising its valuation to $1.64 billion. This investment, which includes both secondary and primary capital, aims to enhance talent retention, strengthen Vi’s platform, and support the development of new products.
Major shareholders in this latest funding round include prominent firms such as General Atlantic, Revelstoke, and the Pritzker Organization, among others. Their support not only reflects confidence in Vi's business model but also highlights the increasing interest in AI-driven solutions within the healthcare sector.
As demand for innovative healthcare solutions rises, Vi's AI agents mark a notable advancement in integrating technology into patient care. By applying AI capabilities, the company seeks to improve operational efficiencies and health outcomes, potentially establishing a new standard for healthcare delivery.
Looking ahead, Vi's ongoing developments could significantly influence healthcare delivery models, making it crucial for industry stakeholders to keep an eye on advancements in AI applications and their effects on patient engagement and care efficiencies.
The stories that move AI & crypto markets — before the market reacts.
Free. 7am ET. Five stories. 62,400 readers.
